Veracyte Announces New Data Demonstrating That Envisia Genomic Classifier Improves IPF Diagnosis
Go back to Veracyte Announces New Data Demonstrating That Envisia Genomic Classifier Improves IPF Diagnosis| VERACYTE (NASDAQ: VCYT) | Delayed: 53.51 -0.12 (0.22%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $53.63 | 52 Week High | $8.45 | |||
| Open | $53.72 | 52 Week Low | $4.21 | |||
| Day High | $54.72 | P/E | N/A | |||
| Day Low | $52.36 | EPS | $-1.52 | |||
| Volume | 559,419 | |||||
